European Journal of Cancer
Volume 45, Issue 2 , Pages 225-227, January 2009

Cancer clinical trial outcomes: Any progress in tumour-size assessment?

  • Jaap Verweij

      Affiliations

    • Department of Medical Oncology, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 10 704 1331; fax: +31 10 704 1003.
    • ,
  • Patrick Therasse

      Affiliations

    • GlaxoSmithKline Biologicals, Rixensart, Belgium
    • ,
  • Elizabeth Eisenhauer

      Affiliations

    • National Cancer Institute of Canada, Clinical Trials Group, Kingston, ON, Canada
    • ,
  • on behalf of the RECIST working group

Received 17 October 2008; accepted 29 October 2008. published online 10 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(08)00872-1

doi:10.1016/j.ejca.2008.10.025

European Journal of Cancer
Volume 45, Issue 2 , Pages 225-227, January 2009

Article Tools